Evidence map›Paper›PMID 36156076›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2023

The Associations of Individual and Subclasses of Nonesterified Fatty Acids With Disability, and Mobility Limitation in Older Adults: The Cardiovascular Health Study.

Peter D Ahiawodzi, Petra Buzkova, Alice H Lichtenstein, Nirupa R Matthan, Joachim H Ix, Jorge R Kizer, Russell P Tracy, Alice Arnold, Anne B Newman, David Siscovick and 2 more

Open access · greenAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Metabolomic Pathways of Inflammation and Mitochondrial Dysfunction Are Related to Worsening Healthy Aging Index and Mortality.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 1 country.

Peter D AhiawodziDepartment of Public Health, Campbell University College of Pharmacy and Health Sciences, Buies Creek, North Carolina, USA.ORCID 0000-0001-9691-0778
Petra BuzkovaDepartment of Biostatistics, University of Washington, Seattle, Washington, USA.
Alice H LichtensteinCardiovascular Nutrition Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA.
Nirupa R MatthanCardiovascular Nutrition Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA.
Joachim H IxDivisions of Nephrology-Hypertension, University of California, San Diego, La Jolla, California, USA.
Jorge R KizerCardiology Section, San Francisco VA Health Care System, and Department of Medicine, Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California,USA.
Russell P TracyDepartment of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, Vermont, USA.
Alice ArnoldDepartment of a Biostatistics, University of Washington, Seattle, Washington, USA.
Anne B NewmanDepartments of Epidemiology and Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-0106-1150
David SiscovickDivision of Research, Evaluation and Policy, The New York Academy of Medicine, New York, New York, USA.
Luc DjousseDivision of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-9902-3047
Kenneth J MukamalDivision of General Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-8450-6970
Tufts University · USUniversity of Washington · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USCampbell University · USNew York Academy of Medicine · USUniversity of California San Diego · USUniversity of California, San Francisco · USUniversity of Pittsburgh · USUniversity of Vermont · US

Funding

Exceptional Survival: Trajectories to Functional Aging (CHS All Stars)R01AG023629 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NEWMAN, ANNE B. · 2004 to 2016
$9.5M
NHLBI NIH HHSNIA NIH HHS R01 AG023629NINDS NIH HHS R01AG023629
6 · The paper itself

Abstract

backgroundWe sought to determine the associations between individual nonesterified fatty acids (NEFAs) and disability and mobility limitation.

methodsWe studied 1 734 participants in the Cardiovascular Health Study (CHS), an ongoing population-based cohort study of community-living older American adults. We measured 35 individual NEFA species in fasting serum samples obtained at the 1996-1997 clinic visit. Using yearly assessments of activities of daily living and self-reported mobility, we identified participants with incident disability or mobility limitation during 15 years of follow-up. Cox proportional hazards regression models were used to determine the associations between per SD increment in the individual NEFAs and incident disability and mobility limitations with adjustment for potential confounding factors.

resultsHigher concentrations of total and a broad range of individual NEFA species were associated with risk of disability and mobility limitation (disability: HR per SD of total NEFA [SD = 174.70] = 1.11, 95% CI = 1.04-1.18, p = .001; mobility limitation: HR per SD of total NEFA = 1.09, 95% CI = 1.02-1.16, p = .01). Among individual saturated NEFAs (SFAs), myristic (14:0) and palmitic (16:0) acids were significantly associated with higher risk of both disability and mobility limitations, but longer-chain FAs were not. Most individual monounsaturated (MUFA), n-6 polyunsaturated fatty acids (PUFAs), and trans FAs were positively significantly associated with higher risks of both disability and mobility limitation. In contrast, most n-3 PUFA species were not associated with disability or mobility limitation.

conclusionsHigher risks of disability and mobility limitation were observed for proinflammatory intermediate-chain SFAs, MUFAs, n-6 PUFAs, and trans FAs. Our findings indicated no significant association for anti-inflammatory n-3 PUFAs.

Indexed as

Fatty Acids, NonesterifiedMobility LimitationActivities of Daily LivingAgedCohort StudiesFatty AcidsFatty Acids, MonounsaturatedFatty Acids, UnsaturatedHumansProspective StudiesRisk FactorsFatty AcidsFatty Acids, MonounsaturatedFatty Acids, NonesterifiedFatty Acids, UnsaturatedDisabilityMobility limitationNonesterified fatty acids

Identifiers

PMID36156076
PMCPMC10329219
OpenAlexW4297221202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.